Efalizumab and dermatitis Patient Reports February 11, 2012



Efalizumab Side Effects Report #4988898-X
Efalizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Male patient, 54 years of age, was diagnosed with psoriasis, crohn's disease What is  crohn's disease and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased, condition aggravated, crohn's disease What is  crohn's disease, dermatitis, mycosis fungoides, psoriasis, rash pruritic. Efalizumab dosage: 1 MG/KG, SUBCUTANEOUS. During the same period patient was treated with INFLIXIMAB. Patient recovered.

Efalizumab Side Effects Report #5090729-7
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 15, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, psoriasis, rash erythematous, rash pruritic, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient recovered.

Efalizumab Side Effects Report #5107058-5
Efalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Sept 05, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, psoriasis, rash erythematous, rash pruritic, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5159329-4
Efalizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 03, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood cholesterol increased, blood pressure systolic increased, condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, psoriasis, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #4848087-6
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 23, 2005. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient recovered.

Efalizumab Side Effects Report #4906893-3
Efalizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 04, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, rash erythematous, rash pruritic, skin disorder, skin oedema, skin ulcer. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient recovered.

Efalizumab Side Effects Report #4917797-4
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 03, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, pruritus, rash What is  rash, rash erythematous, skin oedema, skin ulcer. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient recovered.

Efalizumab Side Effects Report #4998728-8
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on May 05, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis, hyperkeratosis, lymphocytosis, parakeratosis. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOS CREAM. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Efalizumab